A detailed history of Acadian Asset Management LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 343,672 shares of RZLT stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
343,672
Previous 184,502 86.27%
Holding current value
$1.47 Million
Previous $792,000 110.23%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.13 - $5.31 $657,372 - $845,192
159,170 Added 86.27%
343,672 $1.67 Million
Q2 2024

Aug 06, 2024

BUY
$2.29 - $5.79 $215,617 - $545,163
94,156 Added 104.22%
184,502 $792,000
Q1 2024

May 10, 2024

BUY
$0.95 - $2.55 $85,828 - $230,382
90,346 New
90,346 $229,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $166M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.